SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-18-050654
Filing Date
2018-02-21
Accepted
2018-02-20 18:49:32
Documents
1
Group Members
JOINT STOCK CO PHARMSTANDARD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d543703dsc13ga.htm SC 13G/A 59885
  Complete submission text file 0001193125-18-050654.txt   61520
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89601 | Film No.: 18626436
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10A, RUE HENRI SCHNADT LUXEMBOURG N4 L-2530
Business Address 10A, RUE HENRI SCHNADT LUXEMBOURG N4 L-2530 352 24840131
Pharmstandard International S.A. (Filed by) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A